What Researchers Did
The author reviewed laboratory and early clinical evidence on whether adding oxygen to radiation therapy could improve cancer treatment.
What They Found
This review states that oxygen is one of the most potent sensitizers of mammalian cells studied, and that solid tumors in animals and humans contain hypoxic (low-oxygen) but viable cells. In experimental animals, hyperbaric oxygen improved radiation therapy even when treatment was highly fractionated and spread over 3 to 4 1/2 weeks. The author calls this strong evidence that results in at least some human tumors may improve with hyperbaric oxygen, but admits that clinical trials of hyperbaric oxygen with radiation therapy showed no marked improvement. The author adds that the trials were early and based on small numbers, and that they may show a modest but clinically important improvement as they mature.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a narrative review from 1968, and the author notes that the clinical trials it discusses were early and based on small numbers, so their findings were not firm.